CCRM is a Canadian public-private partnership established with seed funding by the Government of Canada and the Province of Ontario, and leading academic and industry partners. It supports the development of regenerative medicine-based technologies and cell and gene therapies. CCRM accelerates the translation of scientific discovery into new companies and marketable products for patients. In 2022, CCRM established OmniaBio Inc., a pre-clinical to commercial-scale CDMO for manufacturing gene-modified cells and viral vectors.

Centre for Commercialization of Regenerative Medicine (CCRM) logo



Event details

Date: June 3 - 6, 2024

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


42 in total